VVEO3 logo

CM Hospitalar S/A Stock Price

BOVESPA:VVEO3 Community·R$492.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 15 Fair Values set on narratives written by author

VVEO3 Share Price Performance

R$1.49
-0.50 (-25.13%)
R$1.49
-0.50 (-25.13%)
Price R$1.49

VVEO3 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
1 Reward

CM Hospitalar S/A Key Details

R$11.4b

Revenue

R$10.0b

Cost of Revenue

R$1.3b

Gross Profit

R$2.3b

Other Expenses

-R$996.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-3.16
11.82%
-8.77%
179.0%
View Full Analysis

About VVEO3

Founded
2010
Employees
n/a
CEO
Leonardo Byrro
WebsiteView website
ri.viveo.com.br

CM Hospitalar S/A engages in the distribution of hospital materials, medicines, and nutrition products in Brazil. The company offers ophthalmic agent, adrenergic and thrombopoietin agonist, aminoglycosides, painkiller, anesthetics, receptor antagonist, anti-hemorrhoidal, antihypertensives, systemic antihistamine, and orthopedic therapy materials; and anti-inflammatories, anti-TNF, antacid, antiandrogen, antianemic, anti-asthmatic, antibiotic, anticoagulant, anticonvulsant, monoclonal antibody, antineoplastics, antiparathyroid drugs, antiparkinsonian, antipsychotic, systemic antipsoriasis, antirheumatics, anti-varicose, anti-growth, antidepressant, antidiabetic, antidiuretic, antidote, antiemetics and antinauseants, anti-migraine, antiepileptics, antiestrogens, antifibrinolytic, antiflatulent, antifungal, antihemorrhagic, antimicrobial, and antiviral medicines. It also provides beta blocker, carbohydrate, cycloplegic, contraceptive, contrast, special control, corticosteroid, topical debrider, diuretic, electrolyte, pancreatic enzyme, erythropoietin, uterine and cardiac stimulant, growth factor, granulocyte colony stimulating factor, gastroprokinetic, systemic hemostatic, heparins, hepatoprotector and lipotropic, hormone, adeno-pituitary and growth hormone, immunoglobulin, immunosuppressant, labor inducer, proton pump and phosphodiesterase inhibitor, bone resorption inhibitor, platelet aggregation inhibitor, adenosine diphosphate receptor antagonist, proton pump and interleukin inhibitor, proprotein convertase subtilisin/kexin type 9 inhibitor, and calcium reabsorption inhibitor medicines. In addition, the company distributes orthopedic products, compression socks, and diapers; and transports medical and hospital cargo. Further, it provides support infrastructure and assistance, as well as pharmaceutical monitoring to patients at home; and offers wipes and wet towels. CM Hospitalar S/A was incorporated in 2010 and is headquartered in Ribeirão Preto, Brazil.

Recent VVEO3 News & Updates

Recent updates

No updates